From 1 October 2021, the new Therapeutic Goods Administration (TGA) regulations stipulated that consumers in Australia must present a valid prescription from an Australian medical practitioner for all purchases of nicotine-based e-vapour products, including products dispensed in Australia or imported from overseas. As a result, specialist clinics responded to the new regulations by rolling out online services and user-friendly processes, and hence legal sales continued their growth momentum.
Vaping continues to attract rising numbers of consumers, both existing smokers and younger generations. The number of smokers quitting cigarettes and migrating to e-vapour products continues to accelerate in Australia, as it is considered a “safer” option or a tool to help them reduce their nicotine intake and eventually to quit smoking.
In 2021, Australian manufacturer Liber Pharmaceuticals started suppling retail pharmacies in Australia with its e-vapour product Nicovape Q and Nicovape SD devices. Nicovape Q is a closed system format which consists of a rechargeable device and single use cartridges.
Although a considerable number of vapers in Australia still purchase closed system single use (disposables), the migration to open vaping systems is accelerating and will continue to do so over the forecast period, due to environmental concerns and price issues of the former. Single use products are no longer considered cost- effective in Australia, although they still attract smokers migrating from cigarettes.
The migration to open vaping systems and e-liquids (refillable pods) will continue to grow over the forecast period, as local consumers consider these options as more eco-friendly, cost-efficient and customisable. With open vaping systems, consumers choose and try different coil resistance and e-liquids, with the ability to control their nicotine intake, unlike single use options.
New Zealand’s recently-implemented Smokefree Environments and Regulated Products (Vaping) Amendment Act (which comprises several measures including allowing general retailers to sell only three flavours of e-liquids, while specialist retailers sell the full range), have promoted calls from Australian industry associations to follow suit, especially after the new regulations requiring prescriptions for nicotine-based e-vapour products were introduced.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Smokeless Tobacco and Vapour Products industry in Australia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Smokeless Tobacco and Vapour Products industry in Australia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Smokeless Tobacco and Vapour Products
Combined total of the four categories: Smokeless (including moist snuff and chewing tobacco), e-vapour products, heated tobacco and tobacco free oral nicotine.See All of Our Definitions
This report originates from Passport, our Smokeless Tobacco and Vapour Products research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!